Clinical Trial Update: TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports completion of the evaluation of TheraSphere selective internal radiation therapy for neuroendocrine tumors with liver…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastasis
• Neuroendocrine Tumor

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Imperial College London | Conditions: Neuroendocrine Tumors, Liver Metastases | Phase 2 | Status: COMPLETED